GSK receives EU orphan drug designation for B7-H3 ADC in lung cancer

Investing.comTuesday, October 28, 2025 at 11:22:29 AM
GSK receives EU orphan drug designation for B7-H3 ADC in lung cancer
GSK has received orphan drug designation from the EU for its B7-H3 antibody-drug conjugate (ADC) aimed at treating lung cancer. This designation is significant as it provides GSK with various incentives to expedite the development and approval process for this promising treatment. The recognition highlights the potential of B7-H3 ADC to address unmet medical needs in lung cancer patients, offering hope for improved outcomes in a challenging area of oncology.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Russian LNG Will Find New Markets After EU Ban, Novatek CEO Says
PositiveFinancial Markets
Leonid Mikhelson, CEO of Novatek, has expressed optimism that Russia's liquefied natural gas (LNG) will successfully find new markets following the European Union's decision to ban imports by 2027. This shift is significant as it highlights the resilience of the Russian energy sector and its ability to adapt to changing global dynamics, potentially opening up new opportunities for trade and investment.
Profusa outlines EU launch of tissue oxygen monitoring in 2026
PositiveFinancial Markets
Profusa has announced its plans to launch a groundbreaking tissue oxygen monitoring system in the EU by 2026. This innovative technology aims to provide real-time insights into tissue oxygen levels, which could significantly enhance patient care and treatment outcomes. The launch is particularly important as it represents a step forward in personalized medicine, allowing healthcare providers to make more informed decisions based on accurate data.
EU carmakers ‘days away’ from halting work as chip war with China escalates
NegativeFinancial Markets
Carmakers in the EU are facing a critical situation as they are just days away from halting production due to a severe shortage of semiconductors, particularly from Nexperia, following China's export bans. This crisis highlights the vulnerability of the automotive industry to global supply chain disruptions and could have significant implications for production timelines and economic stability in the region.
UK must reform drug pricing to become life sciences superpower, says GSK boss
PositiveFinancial Markets
GSK's CEO Emma Walmsley has highlighted the urgent need for the UK to reform its drug pricing system to enhance its position as a life sciences leader. With shares rising due to increased profits, Walmsley remains optimistic about resolving the ongoing standoff with the NHS, which is considering proposals to boost spending on new medicines by up to 25%. This reform is crucial not only for the pharmaceutical industry but also for ensuring that patients have access to innovative treatments, ultimately benefiting public health and the economy.
Europe’s Top Drone Maker Eyes Warsaw IPO as EU Funding Surges
PositiveFinancial Markets
WB Electronics SA, Europe's leading drone manufacturer, is planning to go public on the Warsaw stock exchange. This move comes as the company aims to expand its investments in response to increased EU funding for defense initiatives. This is significant not only for the company but also for the European defense sector, as it highlights the growing importance of drone technology in modern warfare and security.
Planning bill could risk UK’s trade deal with EU, ambassador warns – sources
NegativeFinancial Markets
The UK's proposed planning bill, which aims to remove EU-derived environmental protections, could jeopardize its free trade agreement with the EU, warns ambassador Pedro Serrano. This legislation is seen as a move to stimulate economic growth, but the potential fallout could strain relations with Europe, highlighting the delicate balance between economic development and environmental responsibility. As the bill progresses through the House of Lords, the implications for trade and environmental standards are becoming increasingly significant.
GSK Lifts Guidance After Specialty Medicines Boost Sales
PositiveFinancial Markets
GSK has raised its sales growth forecast for 2025, now expecting an increase of 6% to 7% excluding currency fluctuations, a significant improvement from the previous estimate of 3% to 5%. This positive shift is largely attributed to the strong performance of its specialty medicines, highlighting the company's successful strategy in this segment and its potential for future growth.
EU rules not a barrier to telcos scaling up, senior EU official says
PositiveFinancial Markets
A senior EU official has stated that current regulations should not hinder telecommunications companies from expanding their operations. This is significant as it reassures the industry that they can grow and innovate without excessive regulatory constraints, which could lead to improved services for consumers and increased competition in the market.
Latest from Financial Markets
Citibank Slashes Base Lending Rate to 7.00% Effective Today – A Game-Changer for Borrowers in Tough Times
PositiveFinancial Markets
Citibank has made a significant move by reducing its base lending rate to 7.00%, effective immediately. This decision is a game-changer for borrowers, especially in challenging economic times when many are seeking relief from high interest rates. By lowering the cost of borrowing, Citibank aims to support individuals and businesses alike, making loans more accessible and affordable. This could stimulate spending and investment, ultimately benefiting the broader economy.
Inflation Risks to Keep Gold Attractive, Weaken Bonds
PositiveFinancial Markets
Gold prices are on the rise as inflation risks persist, according to Harbor Capital. With Federal Reserve Chair Jerome Powell highlighting these risks, investors may consider shifting their portfolios by selling bonds and investing in gold. This trend is significant as it reflects a growing confidence in gold as a safe haven during uncertain economic times.
This or That: Bull market or bust?
NeutralFinancial Markets
In a lively segment titled 'This or That,' Sonali Basak, the Chief Investment Strategist for iCapital, engages in a rapid-fire game discussing the current state of the market. This playful yet insightful exchange sheds light on the contrasting views of a potential bull market versus a downturn, making it relevant for investors looking to navigate these uncertain times.
The uncomfortable secret of successful people: Forget work-life balance, you have to be ‘obsessed’, ex-Wall Streeter and business coach says
NeutralFinancial Markets
A former Wall Street professional and business coach argues that true success requires an obsession with one's goals rather than a focus on work-life balance. She emphasizes that this relentless pursuit can lead to inevitable victory, suggesting that those who are willing to think and act continuously are more likely to achieve their dreams. This perspective challenges conventional views on balancing personal and professional life, sparking a conversation about the sacrifices often necessary for success.
Meta Platforms stock price target lowered to $875 at Truist Securities
NegativeFinancial Markets
Truist Securities has lowered its stock price target for Meta Platforms to $875, reflecting concerns about the company's future performance. This adjustment is significant as it indicates a lack of confidence in Meta's growth prospects, which could impact investor sentiment and the overall market. Investors will be closely watching how Meta responds to these challenges and whether it can regain momentum.
Truist Securities reiterates Buy rating on Glaukos stock after strong Q3
PositiveFinancial Markets
Truist Securities has reaffirmed its Buy rating on Glaukos stock following a strong performance in the third quarter. This endorsement is significant as it reflects confidence in Glaukos' growth potential and market position, which could attract more investors and positively influence the stock's trajectory.